Supplementary Figures S1-S7 from Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade
Authors:
- Xing WeiXWXing Wei
- Cristina BlajCBCristina Blaj
- M. Ali Al-RadhawiMAM. Ali Al-Radhawi
- Lick Pui LaiLLLick Pui Lai
- Benjamin J. MaldonatoBMBenjamin J. Maldonato
- Yu Chi YangYYYu Chi Yang
- Lillian SeuLSLillian Seu
- Harika GundlapalliHGHarika Gundlapalli
- Lingyan JiangLJLingyan Jiang
- Mariela A. Moreno AyalaMAMariela A. Moreno Ayala
- Jessica N. SpradlinJSJessica N. Spradlin
- Brett GarrickBGBrett Garrick
Open Access
- 1 June 2026
- other
- Published by American Association for Cancer Research (AACR)